ArticleBritish journal of cancer2018

Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis.

Christoph Krisp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.